Microchip Technology Incorporated — Form 10-Q Summary
Business Context and Reporting Period
Microchip designs, manufactures, and sells embedded-control semiconductor products, including microcontrollers, analog products, FPGAs, memory, and related technologies. It also licenses SuperFlash and other intellectual property. The report covers the three and nine months ended December 31, 2022, the third quarter of fiscal 2023. Results are unaudited and presented under U.S. GAAP.
Key Financial Metrics
| Metric | Q3 FY2023 | Q3 FY2022 | First 9 Months FY2023 | First 9 Months FY2022 |
|---|---|---|---|---|
| Net sales | $2.169 billion | $1.758 billion | $6.206 billion | $4.977 billion |
| Gross profit | $1.471 billion | $1.153 billion | $4.179 billion | $3.229 billion |
| Gross margin | 67.8% | 65.6% | 67.3% | 64.9% |
| Operating income | $811.6 million | $515.0 million | $2.268 billion | $1.300 billion |
| Operating margin | 37.4% | 29.3% | 36.5% | 26.1% |
| Net income | $580.3 million | $352.8 million | $1.634 billion | $847.6 million |
| Diluted EPS | $1.04 | $0.62 | $2.93 | $1.50 |
| Operating cash flow | Not separately provided | Not separately provided | $2.912 billion | $2.095 billion |
Q3 revenue increased 23.4% year over year, while nine-month revenue increased 24.7%. Net income rose 64.5% in Q3 and 92.7% for the first nine months. Management attributed revenue growth primarily to strong demand, price increases, and strength across product lines. Higher factory utilization supported gross-margin expansion.
- Q3 product-line revenue: microcontrollers $1.221 billion, analog $606.5 million, and other products $341.4 million.
- Microcontroller revenue increased 25.6% year over year in Q3; analog revenue increased 21.2%.
- Research and development expense increased 15.1% in Q3 to $282.4 million, but declined to 13.0% of sales from 14.0%.
- SG&A increased 14.3% to $202.9 million, while declining to 9.4% of sales from 10.1%.
- Acquired-intangible amortization declined to $167.4 million from $215.7 million.
- Cash and cash equivalents were $288.9 million at December 31, 2022, versus $317.4 million at March 31, 2022.
- Inventory increased to $1.165 billion from $854.4 million, or 152 days versus 125 days at March 31, 2022.
Debt, Liquidity, and Capital Allocation
- Net long-term debt was $6.589 billion at December 31, 2022, compared with $7.687 billion at March 31, 2022. Principal debt outstanding was $6.620 billion.
- The company had $253.0 million outstanding under its $2.75 billion revolving credit facility, compared with $1.399 billion at March 31, 2022. The facility terminates in December 2026.
- Debt maturities include $3.400 billion in fiscal 2024, $1.678 billion in fiscal 2025, and $1.200 billion in fiscal 2026. The 2023 notes are classified as long-term because management intends and is able to refinance them using the revolving facility.
- Operating cash flow of $2.912 billion exceeded capital expenditures of $373.5 million. Investing cash outflow was $448.7 million.
- Financing cash outflow was $2.491 billion, including debt repayments, $671.9 million of share repurchases, and $499.4 million of dividends.
- The company expects $400 million to $500 million of capital expenditures during the next twelve months, funded through cash and operating cash flow.
- Approximately $2.90 billion remained available under the $4.00 billion share-repurchase authorization at December 31, 2022.
- A quarterly dividend of $0.358 per share was declared on February 2, 2023, with an expected aggregate payment of approximately $196 million.
- Management believes existing liquidity, operating cash flow, and revolver availability will be sufficient for anticipated requirements for at least the next twelve months.
Material Changes Versus the Prior Comparable Period
- Revenue, operating income, net income, and diluted EPS increased substantially year over year.
- Gross margin expanded 220 basis points in Q3 and 240 basis points for the first nine months, primarily from higher factory utilization.
- Interest expense declined to $52.8 million in Q3 from $62.1 million, and to $156.4 million for the first nine months from $199.2 million, mainly because of debt paydown and adoption of ASU 2020-06.
- There was no Q3 debt-settlement loss, versus a $16.1 million loss in the prior-year quarter. The first nine months included an $8.3 million settlement loss versus $101.6 million in the prior-year period.
- Cash collections under long-term supply agreements materially increased deferred revenue to $673.3 million from $117.6 million at March 31, 2022. Approximately $4 billion of LTSA performance obligations remained, with about 10% expected to be recognized over the next twelve months.
- On April 1, 2022, the company adopted ASU 2020-06, increasing reported convertible debt by $105.8 million and increasing opening retained earnings by $46.5 million.
Guidance, Outlook, Risks, and Unusual Items
- Management expects certain supply-chain constraints to persist through much of calendar 2023, although supply has gradually improved.
- Management expects March 31, 2023 inventory days of 157 to 164, above the 152 days reported at December 31, 2022.
- Demand remained strong, but China was adversely affected by COVID-19 lockdowns and subsequent infection increases. Rising interest rates, inflation, and potential global economic weakness could reduce demand.
- Approximately 63% of net sales were from products manufactured at outside wafer foundries, increasing dependence on third-party capacity and suppliers.
- Restructuring charges in Q3 related primarily to acquired and existing wafer-fabrication operations. Nine-month special income primarily reflected favorable resolution of a previously accrued legal matter, partly offset by restructuring costs.
- The company recorded a $40 million award to Continental in an arbitration matter and may face future recall costs, which management does not expect to be material.
- Pending shareholder derivative litigation related to the Microsemi acquisition remains unresolved. The company estimates aggregate potential liability that is possible but not probable at approximately $100 million above accrued amounts.
- The IRS transfer-pricing dispute for fiscal 2007 through fiscal 2012 remains pending. Management believes the assessment lacks merit, but an adverse outcome could materially affect financial position, results, or cash flows.
- The company expects the 15% Corporate AMT under the Inflation Reduction Act to apply beginning in fiscal 2024 and is evaluating its effect.
- Other key risks include semiconductor cyclicality, pricing pressure, customer and distributor concentration, inventory growth, manufacturing yields, foreign operations, trade restrictions, cybersecurity, intellectual-property claims, tax audits, and refinancing risk.
Most Important Facts for Investors to Verify
- Whether strong demand and elevated factory utilization continue as supply constraints ease and macroeconomic conditions weaken.
- The conversion or refinancing plan for the $3.4 billion of fiscal 2024 maturities and the company’s ability to maintain liquidity while funding dividends, repurchases, and capital expenditures.
- Whether inventory days rise toward or above the projected 157-to-164-day range and whether customer or distributor inventories create future revenue pressure.
- The sustainability of the 67.8% quarterly gross margin after supply conditions normalize and pricing pressure returns.
- The timing and collectability of deferred revenue and LTSA-related cash deposits, including potential future customer refunds.
- Developments in the IRS tax dispute, shareholder derivative litigation, Continental-related recall exposure, and other contingencies.
- The effect of China demand, export controls, tariffs, COVID-19 disruptions, and reliance on outside foundries and assembly/test contractors.